Xiangmin Cui

Verified

Managing Director at Decheng CapitalListed on SEC Form ADVMenlo Park, United States

Claim this profile

Warm

Check Size

Not yet known

Reliability Score

🎯100% of deals in Other Technology

Investment Timeline

Levitas

Board seat (SEC Form D)Source

Since Jan 2021

Company last raised Apr 2024

Portfolio Breakdown

By Sector

Other Technology1 deal · 100%

By Stage

1 tracked deal1 sector · 0 stages

Deal Velocity

Avg Deals / Year

1.0

Avg Deal Size

Unknown

Largest Deal

Levitas

Unknown

YoY Trend

Steady

Deals Per Year

1 total deal tracked2021–2021

Investment Activity Map

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

2021

Less

Current Fund Status

Fund Name

Decheng Capital China Life Sciences Usd Fund III, L.P.

Reported Size

$625.9M

Co-Investors

No co-investment data available yet.